Literature DB >> 8680738

Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter.

U Wenzel1, D T Thwaites, H Daniel.   

Abstract

1. The stereoselective transport of beta-lactam antibiotics has been investigated in the human intestinal epithelial cell line, Caco-2, by use of D- and L-enantiomers of cephalexin and loracarbef as substrates. 2. The L-isomers of cephalexin, loracarbef and dipeptides displayed a higher affinity for the oligopeptide/H(+)-symporter in Caco-2 cells than the D-isomers. This was demonstrated by inhibition of the influx of the beta-lactam, [3H]-cefadroxil. 3. By measurement of the substrate-induced intracellular acidification in Caco-2 cells loaded with the pH-sensitive fluorescent dye BCECF (2',7'-bis(2-carboxyethyl)-5-(6)-carboxy-fluorescein), it was demonstrated for the first time that L-isomers of beta-lactams not only bind to the peptide transporter with high affinity but are indeed transported. 4. Efficient proton-coupled transport of L-beta-lactam antibiotics was also shown to occur in Xenopus laevis oocytes expressing the cloned peptide transporter PepT1 from rabbit small intestine. 5. Both cell systems therefore express a stereoselective transport pathway for beta-lactam antibiotics with very similar characteristics and may prove useful for screening rapidly the oral availability of peptide-derived drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8680738      PMCID: PMC1909205          DOI: 10.1111/j.1476-5381.1995.tb15958.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Beta-Lactam antibiotics (1).

Authors:  G R Donowitz; G L Mandell
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

2.  Beta-lactam antibiotics and transport via the dipeptide carrier system across the intestinal brush-border membrane.

Authors:  A Tsuji; I Tamai; H Hirooka; T Terasaki
Journal:  Biochem Pharmacol       Date:  1987-02-15       Impact factor: 5.858

Review 3.  Mechanisms of peptide transport.

Authors:  D M Matthews
Journal:  Beitr Infusionther Klin Ernahr       Date:  1987

4.  Carrier-mediated transport system for cephalexin in human placental brush-border membrane vesicles.

Authors:  Y Kudo; T Urabe; A Fujiwara; K Yamada; T Kawasaki
Journal:  Biochim Biophys Acta       Date:  1989-01-30

5.  Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

Authors:  A H Dantzig; L Bergin
Journal:  Biochim Biophys Acta       Date:  1990-09-07

6.  Characterization of the oral absorption of beta-lactam antibiotics. II. Competitive absorption and peptide carrier specificity.

Authors:  P J Sinko; G L Amidon
Journal:  J Pharm Sci       Date:  1989-09       Impact factor: 3.534

7.  Characterization of the oral absorption of beta-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ.

Authors:  P J Sinko; G L Amidon
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

8.  H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.

Authors:  K Inui; T Okano; H Maegawa; M Kato; M Takano; R Hori
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

9.  Stereospecific absorption and degradation of cephalexin.

Authors:  I Tamai; H Y Ling; S M Timbul; J Nishikido; A Tsuji
Journal:  J Pharm Pharmacol       Date:  1988-05       Impact factor: 3.765

10.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

View more
  14 in total

1.  Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.

Authors:  N J Snyder; L B Tabas; D M Berry; D C Duckworth; D O Spry; A H Dantzig
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin.

Authors:  Hugues Chanteux; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT.

Authors:  Shintaro Doki; Hideaki E Kato; Nicolae Solcan; Masayo Iwaki; Michio Koyama; Motoyuki Hattori; Norihiko Iwase; Tomoya Tsukazaki; Yuji Sugita; Hideki Kandori; Simon Newstead; Ryuichiro Ishitani; Osamu Nureki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

4.  PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers.

Authors:  Uwe Wenzel; Sabine Kuntz; Simone Diestel; Hannelore Daniel
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).

Authors:  Catriona M H Anderson; Maria E Mendoza; David J Kennedy; Demetrio Raldua; David T Thwaites
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.

Authors:  Claire Colas; Masayuki Masuda; Kazuaki Sugio; Seiji Miyauchi; Yongjun Hu; David E Smith; Avner Schlessinger
Journal:  Mol Pharm       Date:  2017-11-15       Impact factor: 4.939

7.  The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.

Authors:  Yasuhiro Tsume; Tuba Incecayir; Xueqin Song; John M Hilfinger; Gordon L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2013-12-19       Impact factor: 5.571

8.  Functional implications and ubiquitin-dependent degradation of the peptide transporter Ptr2 in Saccharomyces cerevisiae.

Authors:  Ken Kawai; Atsuto Moriya; Satoshi Uemura; Fumiyoshi Abe
Journal:  Eukaryot Cell       Date:  2014-08-29

9.  Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.

Authors:  Simon Newstead; David Drew; Alexander D Cameron; Vincent L G Postis; Xiaobing Xia; Philip W Fowler; Jean C Ingram; Elisabeth P Carpenter; Mark S P Sansom; Michael J McPherson; Stephen A Baldwin; So Iwata
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

10.  Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.

Authors:  Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal:  Mol Pharm       Date:  2008-07-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.